{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:01:36Z","timestamp":1794002496804,"version":"4.8.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>Neutropenic sepsis is a high-risk form of sepsis associated with rapid deterioration and high mortality. Although early antibiotic administration is recommended, the benefit of shorter time to antibiotics (TTA) remains uncertain. This study aimed to determine the relationship between TTA and in-hospital mortality for patients with neutropenic sepsis and to identify specific phenotypes most vulnerable to TTA delays.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>Prospective, multicenter observational cohort study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting:<\/jats:title>\n                    <jats:p>Twenty tertiary or university-affiliated hospitals in South Korea.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients:<\/jats:title>\n                    <jats:p>In this prospective multicenter cohort study, we analyzed 942 patients with sepsis and neutropenia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>None.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results:<\/jats:title>\n                    <jats:p>\n                      TTA was categorized into three groups: less than 1 hour (early), 1\u20133 hours (intermediate), and greater than or equal to 3 hours (delayed). We used inverse probability of treatment weighting (IPTW) with logistic regression to evaluate the association between TTA and in-hospital mortality and a causal forest model to identify characteristics associated with the effect of longer TTA. Overall, 211, 531, and 200 patients belonged to the early, intermediate, and delayed groups, respectively. In IPTW-weighted logistic regression, odds ratio (OR) for in-hospital mortality was significantly higher in the delayed (OR: 1.50; 95% CI, 1.22\u20131.85;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.001) and intermediate groups (OR: 1.26; 95% CI, 1.04\u20131.53;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.021) than in the early group. The association between longer TTA and mortality was stronger among patients with septic shock and among those with hematologic malignancy in both models. The causal forest further identified elevated lactate as a potential effect modifier, indicating greater estimated benefit from earlier TTA; however, interaction tests in the weighted logistic model were not significant.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Delayed antibiotic administration was associated with increased in-hospital mortality among patients with neutropenic sepsis. The impact on in-hospital mortality is heterogeneous, varying by patient characteristics, particularly septic shock and hematologic malignancy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ccm.0000000000007184","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T14:00:15Z","timestamp":1780495215000},"page":"1849-1858","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Impact of Time to Antibiotics on In-hospital Mortality in Neutropenic Sepsis: A Prospective Multicenter Cohort Study"],"prefix":"10.1097","volume":"54","author":[{"given":"Dongju","family":"Kim","sequence":"first","affiliation":[{"name":"All authors: Department of Emergency Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youn-Jung","family":"Kim","sequence":"additional","affiliation":[{"name":"All authors: Department of Emergency Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Mok","family":"Ryoo","sequence":"additional","affiliation":[{"name":"All authors: Department of Emergency Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6904-5966","authenticated-orcid":false,"given":"Won Young","family":"Kim","sequence":"additional","affiliation":[{"name":"All authors: Department of Emergency Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"On behalf of the Korean Sepsis Alliance (KSA) Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"key":"R1-20260806","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMoa1703058","article-title":"Time to treatment and mortality during mandated emergency care for sepsis.","volume":"376","author":"Seymour","year":"2017","journal-title":"N Engl J Med"},{"key":"R2-20260806","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1093\/cid\/ciad450","article-title":"Risk of misleading conclusions in observational studies of time-to-antibiotics and mortality in suspected sepsis.","volume":"77","author":"Pak","year":"2023","journal-title":"Clin Infect Dis"},{"key":"R3-20260806","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.chest.2019.02.008","article-title":"ED door-to-antibiotic time and long-term mortality in sepsis.","volume":"155","author":"Peltan","year":"2019","journal-title":"Chest"},{"key":"R4-20260806","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: International guidelines for management of sepsis and septic shock 2021.","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med"},{"key":"R5-20260806","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.annemergmed.2020.04.042","article-title":"Outcome of immediate versus early antibiotics in severe sepsis and septic shock: A systematic review and meta-analysis.","volume":"76","author":"Rothrock","year":"2020","journal-title":"Ann Emerg Med"},{"key":"R6-20260806","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s13054-015-0936-3","article-title":"The association between time to antibiotics and relevant clinical outcomes in emergency department patients with various stages of sepsis: A prospective multi-center study.","volume":"19","author":"De Groot","year":"2015","journal-title":"Crit Care"},{"key":"R7-20260806","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/jama.2018.12179","article-title":"Antibiotics for sepsis\u2014finding the equilibrium.","volume":"320","author":"Klompas","year":"2018","journal-title":"JAMA"},{"key":"R8-20260806","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1164\/rccm.201703-0621ED","article-title":"Antibiotics for sepsis: Does each hour really count, or is it incestuous amplification?","volume":"196","author":"Singer","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"R9-20260806","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1164\/rccm.202310-1800OC","article-title":"Heterogeneity of benefit from earlier time-to-antibiotics for sepsis.","volume":"209","author":"Hechtman","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"R10-20260806","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13054-021-03883-0","article-title":"Time-to-antibiotics and clinical outcomes in patients with sepsis and septic shock: A prospective nationwide multicenter cohort study.","volume":"26","author":"Im","year":"2022","journal-title":"Crit Care"},{"key":"R11-20260806","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s13054-023-04507-5","article-title":"Time to treatment and mortality for clinical sepsis subtypes.","volume":"27","author":"Yang","year":"2023","journal-title":"Crit Care"},{"key":"R12-20260806","doi-asserted-by":"crossref","first-page":"644270","DOI":"10.3389\/fphar.2021.644270","article-title":"Targeting neutrophils in sepsis: From mechanism to translation.","volume":"12","author":"Shen","year":"2021","journal-title":"Front Pharmacol"},{"key":"R13-20260806","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1378\/chest.13-2618","article-title":"Sepsis severe or septic shock: Outcome according to immune status and immunodeficiency profile.","volume":"146","author":"Tolsma","year":"2014","journal-title":"Chest"},{"key":"R14-20260806","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/SHK.0000000000001907","article-title":"Clinical characteristics and outcomes of neutropenic sepsis: A multicenter cohort study.","volume":"57","author":"Na","year":"2022","journal-title":"Shock"},{"key":"R16-20260806","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s00277-019-03622-0","article-title":"Management of sepsis in neutropenic cancer patients: 2018 guidelines from the infectious diseases working party (AGIHO) and intensive care working party (iCHOP) of the German society of hematology and medical oncology (DGHO).","volume":"98","author":"Kochanek","year":"2019","journal-title":"Ann Hematol"},{"key":"R17-20260806","first-page":"2799","article-title":"Impact of time to antibiotics on outcomes of chemotherapy-induced febrile neutropenia.","volume":"23","author":"Ko","year":"2015","journal-title":"Support Care Cancer"},{"key":"R18-20260806","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s00134-014-3374-9","article-title":"Neutropenic cancer patients with severe sepsis: Need for antibiotics in the first hour.","volume":"40","author":"Mokart","year":"2014","journal-title":"Intensive Care Med"},{"key":"R19-20260806","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1128\/AAC.02561-14","article-title":"Cohort study of the impact of time to antibiotic administration on mortality in patients with febrile neutropenia.","volume":"58","author":"Rosa","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"R20-20260806","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1097\/CCM.0000000000004493","article-title":"Normothermia in patients with sepsis who present to emergency departments is associated with low compliance with sepsis bundles and increased in-hospital mortality rate*.","volume":"48","author":"Park","year":"2020","journal-title":"Crit Care Med"},{"key":"R21-20260806","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1001\/jama.2016.0288","article-title":"Assessment of clinical criteria for sepsis: For the third international consensus definitions for sepsis and septic shock (Sepsis-3).","volume":"315","author":"Seymour","year":"2016","journal-title":"JAMA"},{"key":"R22-20260806","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3).","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"R23-20260806","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00134-018-5085-0","article-title":"The surviving sepsis campaign bundle: 2018 update.","volume":"44","author":"Levy","year":"2018","journal-title":"Intensive Care Med"},{"key":"R24-20260806","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1093\/aje\/kwad043","article-title":"Practical guide to honest causal forests for identifying heterogeneous treatment effects.","volume":"192","author":"Jawadekar","year":"2023","journal-title":"Am J Epidemiol"},{"key":"R25-20260806","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1080\/01621459.2017.1319839","article-title":"Estimation and inference of heterogeneous treatment effects using random forests.","volume":"113","author":"Wager","year":"2018","journal-title":"J Am Stat Assoc"},{"key":"R27-20260806","doi-asserted-by":"crossref","first-page":"e259","DOI":"10.1097\/PEC.0000000000002241","article-title":"Patient outcomes with febrile neutropenia based on time to antibiotics in the emergency department.","volume":"38","author":"Dessie","year":"2022","journal-title":"Pediatr Emerg Care"},{"key":"R28-20260806","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejim.2024.06.015","article-title":"Door-to-antibiotic time and mortality in patients with sepsis: Systematic review and meta-analysis.","volume":"129","author":"Leung","year":"2024","journal-title":"Eur J Intern Med"},{"key":"R29-20260806","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s13054-016-1398-y","article-title":"Neutropenic sepsis is associated with distinct clinical and biological characteristics: A cohort study of severe sepsis.","volume":"20","author":"Reilly","year":"2016","journal-title":"Crit Care"},{"key":"R30-20260806","first-page":"1369","article-title":"Association of time to antibiotics and clinical outcomes in patients with fever and neutropenia during chemotherapy for cancer: A systematic review.","volume":"28","author":"Koenig","year":"2020","journal-title":"Support Care Cancer"},{"key":"R31-20260806","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/1472-6963-14-162","article-title":"Time to antibiotics and outcomes in cancer patients with febrile neutropenia.","volume":"14","author":"Perron","year":"2014","journal-title":"BMC Health Serv Res"},{"key":"R32-20260806","doi-asserted-by":"crossref","first-page":"7078","DOI":"10.1038\/s41598-025-87457-y","article-title":"Clinical characteristics and prognostic factors of sepsis in patients with malignancy.","volume":"15","author":"Hong","year":"2025","journal-title":"Sci Rep"},{"key":"R33-20260806","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12911-023-02207-2","article-title":"Comparison of causal forest and regression-based approaches to evaluate treatment effect heterogeneity: An application for type 2 diabetes precision medicine.","volume":"23","author":"Venkatasubramaniam","year":"2023","journal-title":"BMC Med Inform Decis Mak"},{"key":"R34-20260806","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical Practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America.","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CCM.0000000000007184","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:38:08Z","timestamp":1786048688000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/CCM.0000000000007184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000007184","relation":{},"ISSN":["0090-3493","1530-0293"],"issn-type":[{"value":"0090-3493","type":"print"},{"value":"1530-0293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]}}}